Literature DB >> 16153568

Inhaled nitric oxide therapy in children.

John P Kinsella1, Steven H Abman.   

Abstract

Inhaled nitric oxide therapy improves oxygenation and reduces the need for treatment with extracorporeal membrane oxygenation in term newborns with hypoxaemic respiratory failure and persistent pulmonary hypertension. In this review, we summarise the current status of iNO therapy in the newborn and the potential role of iNO in other paediatric populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153568     DOI: 10.1016/j.prrv.2005.06.002

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  6 in total

Review 1.  Nitric oxide: considerations for the treatment of ischemic stroke.

Authors:  Nicole A Terpolilli; Michael A Moskowitz; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-15       Impact factor: 6.200

2.  Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension.

Authors:  Satyan Lakshminrusimha; Daniel D Swartz; Sylvia F Gugino; Chang-Xing Ma; Karen A Wynn; Rita M Ryan; James A Russell; Robin H Steinhorn
Journal:  Pediatr Res       Date:  2009-11       Impact factor: 3.756

Review 3.  Etiology, diagnosis, and pharmacologic treatment of pediatric pulmonary hypertension.

Authors:  Robert Tulloh
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

4.  Association of Response to Inhaled Nitric Oxide and Duration of Mechanical Ventilation in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Jasmine C Dowell; Neal J Thomas; Nadir Yehya
Journal:  Pediatr Crit Care Med       Date:  2017-11       Impact factor: 3.624

5.  A review of the use of inhaled nitric oxide in the PICU at Red Cross War Memorial Children's Hospital, 2011-2015: A retrospective cohort study.

Authors:  S Padayachee; S Salie
Journal:  South Afr J Crit Care       Date:  2021-08-06

Review 6.  Treatment of pediatric pulmonary hypertension.

Authors:  Amy Hawkins; Robert Tulloh
Journal:  Vasc Health Risk Manag       Date:  2009-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.